Jacob W. Myerson

3.6k total citations · 1 hit paper
52 papers, 2.1k citations indexed

About

Jacob W. Myerson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Jacob W. Myerson has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Biomaterials. Recurrent topics in Jacob W. Myerson's work include Nanoparticle-Based Drug Delivery (11 papers), Blood properties and coagulation (7 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Jacob W. Myerson is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), Blood properties and coagulation (7 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Jacob W. Myerson collaborates with scholars based in United States, China and Russia. Jacob W. Myerson's co-authors include Alicia M. Jackson, Francesco Stellacci, Vladimir R. Muzykantov, Samuel A. Wickline, Raisa Y. Kiseleva, Elizabeth D. Hood, Vladimir V. Shuvaev, Patrick M. Glassman, Samir Mitragotri and Oscar A. Marcos‐Contreras and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Jacob W. Myerson

51 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions

2024 52 citations Marco E. Zamora, Jichuan Wu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob W. Myerson United States	23	693	579	556	501	309	52	2.1k
Ying Hu United States	23	1.0k 1.5×	587 1.0×	640 1.2×	419 0.8×	397 1.3×	51	2.6k
Kuan‐Ju Chen Taiwan	28	768 1.1×	1.1k 1.8×	434 0.8×	687 1.4×	260 0.8×	78	2.6k
Qiang Luo China	26	590 0.9×	961 1.7×	621 1.1×	491 1.0×	396 1.3×	77	2.9k
Edie C. Goldsmith United States	24	1.1k 1.5×	832 1.4×	848 1.5×	586 1.2×	915 3.0×	36	3.0k
Takahito Kawano Japan	24	930 1.3×	958 1.7×	618 1.1×	804 1.6×	759 2.5×	50	2.6k
Tobias Pfaller Austria	9	534 0.8×	460 0.8×	691 1.2×	726 1.4×	310 1.0×	10	1.9k
Magdalena Swierczewska United States	22	975 1.4×	1.1k 1.9×	500 0.9×	535 1.1×	228 0.7×	32	2.2k
Kimberly S. Butler United States	24	777 1.1×	1000 1.7×	884 1.6×	688 1.4×	152 0.5×	42	2.6k
Tania Limongi Italy	25	740 1.1×	1.2k 2.1×	579 1.0×	480 1.0×	125 0.4×	81	2.6k
M. Ferrari United States	17	546 0.8×	1.0k 1.8×	428 0.8×	1.0k 2.0×	148 0.5×	33	2.2k

Countries citing papers authored by Jacob W. Myerson

Since Specialization

Citations

This map shows the geographic impact of Jacob W. Myerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob W. Myerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob W. Myerson more than expected).

Fields of papers citing papers by Jacob W. Myerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob W. Myerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob W. Myerson. The network helps show where Jacob W. Myerson may publish in the future.

Co-authorship network of co-authors of Jacob W. Myerson

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob W. Myerson. A scholar is included among the top collaborators of Jacob W. Myerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob W. Myerson. Jacob W. Myerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peshkova, Alina D., Jia Nong, Zhicheng Wang, et al.. (2025). Biomechanical and Functional Features of the Carrier Erythrocytes Prolonging Circulation Time of Biotherapeutic Targeted to Glycophorin A. Bioconjugate Chemistry. 36(2). 263–275. 3 indexed citations

Reyes‐Esteves, Sahily, Marco E. Zamora, Yufei Wang, et al.. (2025). Targeted lipid nanoparticles containing IL-10 mRNA improve outcomes in experimental intracerebral hemorrhage. Journal of Neuroinflammation. 22(1). 234–234. 1 indexed citations

Zamora, Marco E., et al.. (2024). Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ Targeting. Nano Letters. 8 indexed citations

Nong, Jia, Jacob W. Myerson, Patrick M. Glassman, et al.. (2024). Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy. Journal of Controlled Release. 374. 425–440. 6 indexed citations

Reyes‐Esteves, Sahily, Jia Nong, Patrick M. Glassman, et al.. (2023). Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage. Journal of Controlled Release. 356. 185–195. 23 indexed citations

Myerson, Jacob W., et al.. (2023). Meta-analysis of material properties influencing nanoparticle plasma pharmacokinetics. International Journal of Pharmaceutics. 639. 122951–122951. 4 indexed citations

Ferguson, Laura T., Jacob W. Myerson, Jichuan Wu, et al.. (2023). Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases. SHILAP Revista de lepidopterología. 3(3). 2200106–2200106. 19 indexed citations

Ferguson, Laura T., Jacob W. Myerson, Jichuan Wu, et al.. (2023). Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases. Advanced NanoBiomed Research. 3(3). 10 indexed citations

Mukhitov, Alexander R., Jia Nong, Jichuan Wu, et al.. (2022). Nanoparticle-Induced Augmentation of Neutrophils’ Phagocytosis of Bacteria. Frontiers in Pharmacology. 13. 923814–923814. 2 indexed citations

10.

Mendes, Lívia P., Kobra Rostamizadeh, Kandace Gollomp, et al.. (2020). Monoclonal antibody 2C5 specifically targets neutrophil extracellular traps. mAbs. 12(1). 1850394–1850394. 10 indexed citations

11.

Glassman, Patrick M., Jacob W. Myerson, Laura T. Ferguson, et al.. (2020). Targeting drug delivery in the vascular system: Focus on endothelium. Advanced Drug Delivery Reviews. 157. 96–117. 101 indexed citations

12.

Marcos‐Contreras, Oscar A., Raisa Y. Kiseleva, Viviana Zuluaga‐Ramirez, et al.. (2019). Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain. Journal of Controlled Release. 301. 54–61. 46 indexed citations

13.

Pan, Daniel C., Jacob W. Myerson, Priyal Patel, et al.. (2018). Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells. Scientific Reports. 8(1). 1615–1615. 103 indexed citations

14.

Parhiz, Hamideh, Makan Khoshnejad, Jacob W. Myerson, et al.. (2018). Unintended effects of drug carriers: Big issues of small particles. Advanced Drug Delivery Reviews. 130. 90–112. 52 indexed citations

15.

Myerson, Jacob W., et al.. (2017). Fluorescence Microscopy Imaging Calibration for Quantifying Nanocarrier Binding to Cells During Shear Flow Exposure. Journal of Biomedical Nanotechnology. 13(6). 737–745. 6 indexed citations

16.

Bhamidipati, Kartik, Patrick M. Glassman, Ramakrishnan Natesan, et al.. (2017). Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions. Nanomedicine Nanotechnology Biology and Medicine. 13(4). 1495–1506. 29 indexed citations

17.

Myerson, Jacob W., John S. Allen, Todd A. Williams, et al.. (2012). PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting. Journal of Cardiovascular Magnetic Resonance. 14(S1). 4 indexed citations

18.

Myerson, Jacob W., He Li, Gregory M. Lanza, Douglas M. Tollefsen, & Samuel A. Wickline. (2011). Abstract 15949: Bivalirudin Nanoparticles Enable Simultaneous Detection and Potent Inhibition of Acute Clotting. Circulation. 124. 1 indexed citations

19.

Cai, Kejia, Lei Zhang, Jacob W. Myerson, et al.. (2009). Dual PARACEST and 19F MR molecular imaging of fibrin clots with targeted perfluorocarbon nanoparticles. Journal of Cardiovascular Magnetic Resonance. 11(S1). 1 indexed citations

20.

Neubauer, Anne M., Jacob W. Myerson, Shelton D. Caruthers, et al.. (2008). Gadolinium‐modulated ¹⁹F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Magnetic Resonance in Medicine. 60(5). 1066–1072. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact